ARIZONA HOUSE OF REPRESENTATIVES 57th Legislature, 2nd Regular Session Majority Research Staff
	Senate: JUD DP 8-0-1-0 | Third Read 34-20-6-0 House: HHS DPA/SE 4-3-0-0 | Third Read 18-11-1-0

---

HB 2048: orders of protection; process servers

NOW: AHCCCS; coverage; non-opioid prescription drugs

Sponsor: Representative Bliss, LD 1

Senate Engrossed

The House Engrossed version of HB 2048 prohibited private process servers from serving orders of protection that grant exclusive possession of a residence to one party in domestic violence cases.

The Senate adopted a strike-everything amendment to HB 2048 that does the following:

Overview

Prohibits the Arizona Health Care Cost Containment System (AHCCCS) from establishing more restrictive utilization controls on non-opioid prescription drugs used to treat chronic or acute moderate to severe pain than those applied to prescription opioid or narcotic drugs.

History

Established in 1981, AHCCCS is Arizona's Medicaid program that oversees contracted health plans for the delivery of health care to individuals and families who qualify for Medicaid and other medical assistance programs. Through contracted health plans across the state, AHCCCS delivers health care to qualifying individuals including low-income adults, their children or people with certain disabilities. Members must meet certain financial and nonfinancial requirements to be eligible for AHCCCS (A.R.S. § 36-2901).

The United States Food and Drug Administration (FDA) is responsible for protecting the public health by ensuring the safety, efficacy and security of human and veterinary drugs, biological products and medical devices (FDA).

Opioids are natural or synthetic chemicals that bind to receptors in your brain or body to reduce the intensity of pain signals reaching the brain. Common prescription opioid drugs include: 1) hydrocodone; 2) oxycodone; and 3) morphine. Prescription opioids can be used to treat acute-to-chronic pain and are often prescribed following surgery or injury or for health conditions such as cancer (CDC).

Provisions

1. Prohibits AHCCCS from establishing more restrictive utilization controls, including prior authorization or step therapy requirements, on any clinically appropriate prescription non-opioid drug approved by the FDA to treat chronic or acute moderate to severe pain that are more restrictive or extensive than the least restrictive or extensive utilization controls applicable to any clinically appropriate prescription opioid or narcotic drug.     (Sec. 1)

2. Contains a repeal date of September 1, 2028. (Sec. 1)

3.

4.

5. ---------- DOCUMENT FOOTER ---------

6. Initials AG/LK                HB 2048

7. 6/1/2026    Page 0 Senate Engrossed

8.

9. ---------- DOCUMENT FOOTER ---------